Vycke Yunivita - Infectious Diseases

Author Information

Vycke Yunivita is a distinguished researcher affiliated with the Department of Biomedical Sciences, Faculty of Medicine at Universitas Padjadjaran in Bandung, Indonesia. Vycke is also an active member of the TB Working Group at the Research Center for Care and Control of Infectious Diseases, Universitas Padjadjaran, underscoring a strong commitment to tackling infectious diseases, particularly tuberculosis.

Research Contributions

Vycke Yunivita has made significant contributions to the field of infectious diseases, with a particular focus on tuberculosis. In recent years, Vycke's research has explored various aspects of tuberculosis treatment, including the pharmacokinetics and safety of key anti-tuberculosis drugs such as isoniazid, rifampicin, and pyrazinamide. Vycke has also investigated the impact of conditions such as diabetes on immune dysfunction in tuberculosis and has participated in clinical trials aimed at improving treatment outcomes for tuberculous meningitis. Notably, Vycke has examined the potential of clofazimine as a treatment for multidrug-resistant tuberculosis and has contributed to the development of methods for drug quantification in human samples.

Aliases

Vycke Yunivita is also known by the aliases V Yunivita and V. Yunivita. These variations of the name are used interchangeably in academic and research publications.

Publication and Citation Metrics

Metric	Value
Total Papers	23
Total Citations	231
H-index	9

Publications:

Clofazimine as a Treatment for Multidrug-Resistant Tuberculosis: A Review

DOI: 10.3390/SCIPHARM89020019

Year: 2021

Pharmacokinetics and safety/tolerability of isoniazid, rifampicin and pyrazinamide in children and adolescents treated for tuberculous meningitis

DOI: 10.1136/archdischild-2020-321426

Year: 2021

Partial Validation of Ultra Performance Liquid Chromatography Method for Quantification of Isoniazid-Pyrazinamide in Human Samples

DOI: 10.21776/ub.jpacr.2021.010.03.600

Year: 2021

Impact of Intermediate Hyperglycemia and Diabetes on Immune Dysfunction in Tuberculosis

DOI: 10.1093/cid/ciaa751

Year: 2020

Annona Muricata L Leaf Infusion Effect on Glucose Absorption in the Intestinal Cells Membrane of Wistar Rats Model

DOI: 10.15850/amj.v6n2.509

Year: 2019

High dose oral rifampicin to improve survival from adult tuberculous meningitis: A randomised placebo-controlled double-blinded phase III trial (the HARVEST study)

DOI: 10.12688/wellcomeopenres.15565.2

Year: 2019

Antituberculosis Drug-induced Hepatotoxicity in Pediatric Tuberculosis

DOI: 10.15850/amj.v6n3.1673

Year: 2019

Adherence to Antihypertensive Medication in Patients with Hypertension in Indonesia

DOI: 10.15850/ijihs.v7n2.1588

Year: 2019

Pharmacokinetics of pyrazinamide during the initial phase of tuberculous meningitis treatment.

DOI: 10.1016/j.ijantimicag.2019.06.010

Year: 2019

Model-Based Meta-analysis of Rifampicin Exposure and Mortality in Indonesian Tuberculous Meningitis Trials

DOI: 10.1093/cid/ciz1071

Year: 2019

Why is PCR Important in Infectious Diseases?

How is Plasmodium falciparum transmitted?

What are the risks associated with Dengvaxia?

What is a Urinary Tract Infection (UTI)?

How Can HIV/AIDS Be Prevented?

How do you handle food and water safety?

What Are Some Common Misconceptions About Monogamy and Infectious Diseases?

What Role Do Vaccinations Play in Public Health?

What are Structural Proteins?

What are the Strengths and Limitations?

Partnered Content Networks

Relevant Topics